SHWZ MEDICINE MAN TECHNOLOGIES INC
- 0.650
- +0.024+3.83%
MEDICINE MAN TECHNOLOGIES INC News
Marijuana Investors Bet Big On Long-Term Growth Over Short-Term Earnings As Market Value Rises By 39%
Recent data from the Viridian Cannabis Deal Tracker highlights significant changes in the valuation multiples of major multi-state operators (MSOs) in the cannabis sector. The Viridian Cannabis Deal T
MEDICINE MAN TECHNOLOGIES INC(SHWZ.US) Officer Buys US$105 in Common Stock
$MEDICINE MAN TECHNOLOGIES INC(SHWZ.US)$ Officer Pabon Daniel purchased 150 shares of common stock on Apr 11, 2024 at an average price of $0.7 for a total value of $105.Source: Announcement What is st
Cannabis Market's Trading Volume Surges Up 292%, Viridian Capital Highlights Mixed Liquidity
A recent analysis by Viridian Capital Advisors provides intriguing insights into the liquidity of cannabis companies, indicating both advancements and setbacks in the sector. Despite an overall increa
Medicine Man Technologies GAAP EPS of -$0.43, Revenue of $43.3M Misses by $2.17M
Schwazze Reports Slight Revenue Drop In Q4 2023 Amid 'Fierce' Competition In Cannabis Retail Sector
Medicine Man Technologies, Inc. (OTC:SHWZ), operating as Schwazze, announced its financial and operational results on Thursday for the fourth quarter and full year ended Dec. 31, 2023."This past year,
Medicine Man Technologies Is Maintained at Buy by Benchmark
Medicine Man Technologies Is Maintained at Buy by Benchmark
Express News | Benchmark Maintains Buy on Medicine Man Technologies, Lowers Price Target to $2.5
Medicine Man Technologies Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/28/2024 190.7% Benchmark $3 → $2.5 Maintains Buy 03/30/2023 248.84% Benchmark → $3 Reiterates → Buy 12/
Earnings Call Summary | MEDICINE MAN TECHNOLOGIES INC(SHWZ.US) Q4 2023 Earnings Conference
The following is a summary of the Medicine Man Technologies, Inc. (SHWZ) Q4 2023 Earnings Call Transcript:Financial Performance:Medicine Man Technologies (Schwazze) reported Q4 revenue of $43.3 millio
Medicine Man Technologies Q4 EPS $(0.38) Misses $(0.13) Estimate, Sales $43.33M Miss $45.47M Estimate
Medicine Man Technologies (OTC:SHWZ) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.13) by 192.31 percent. This is a 22.58 percent decrease over loss
Earnings Flash (SHWZ) SCHWAZZE Reports Q4 Revenue $43.3M
04:14 PM EDT, 03/27/2024 (MT Newswires) -- Earnings Flash (SHWZ) SCHWAZZE Reports Q4 Revenue $43.3M
Press Release: Schwazze Announces Fourth Quarter and Full Year 2023 Financial Results
Schwazze Announces Fourth Quarter and Full Year 2023 Financial Results Canada NewsWire DENVER, March 27, 2024 FY 2023 Revenue of $172.4 Million; Income from Operations of $3.3 Million; Adjusted EBI
Medicine Man Technologies 4Q Rev $43.3M >SHWZ
Medicine Man Technologies 4Q Rev $43.3M >SHWZ
Medicine Man Technologies Q4 2023 Earnings Preview
Notable Earnings After Wednesday's Close
Earnings Outlook For Medicine Man Technologies
Medicine Man Technologies (OTC:SHWZ) is set to give its latest quarterly earnings report on Wednesday, 2024-03-27. Here's what investors need to know before the announcement.Analysts estimate that Med
Schwazze Sets Fourth Quarter and Full Year 2023 Conference Call for March 27, 2024 at 5:00 P.m. ET
Press Release: Schwazze Appoints Forrest Hoffmaster as Interim Chief Executive Officer
Schwazze Appoints Forrest Hoffmaster as Interim Chief Executive Officer PR Newswire DENVER, Feb. 23, 2024 DENVER, Feb. 23, 2024 /PRNewswire/ - Medicine Man Technologies, Inc., operating as Schwazze
Fast Track Recap: Colorado & Michigan Weed Sales Decline, Virginia Eyes Legal Market, Stock Winners & Losers
Colorado's cannabis market, once a frontrunner in the U.S. for recreational marijuana sales, has experienced a downturn. In 2023, the state's cannabis sales barely surpassed the $1.5 billion mark, a d
Colorado Wants To Simplify Cannabis Regulations, Eliminate Fungus Testing: A 500-Page Rulebook Is Too Long, Lawmakers Say
A new bipartisan measure introduced on Monday in Colorado seeks to remove a recently implemented rule that mandates testing of cannabis for a fungus called Aspergillus, as first reported by Westworld.
Analysis
Price Target
No Data
